sur Revolune
Revolune GmbH Launches to Advance Spatial Biology
Oberkochen, Germany - April 15, 2026: Revolune GmbH, a new life science company, officially launches to simplify spatial biology studies. They specialize in streamlined multiplex immunofluorescence (mIF) reagents, enhancing tissue analysis workflows for translational and biopharma research.
Today's biomedical research increasingly relies on spatially resolved biomarker analysis. Traditional multiplex tissue workflows often face technical challenges, hindering broader adoption. Revolune aims to overcome these barriers by providing reagent solutions that enhance clarity and efficiency in tissue analysis.
CEO Florian Leiss emphasizes their mission to "illuminate what matters," focusing on reducing workflow complexity. Leiss, formerly with ZEISS, brings substantial experience in spatial biology. Alongside him, Michaeli Deli joins as CFO to guide Revolune's strategic growth. The company's Early Access Program invites collaboration on developing advanced spatial biology workflows.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Revolune